Research and development costs of new drugs

Research output: Contribution to journal › Comment/Letter to the editor › Scientific › peer-review

Original language	English
Pages (from-to)	516-517
Journal	JAMA. The Journal of the American Medical Association
Volume	324
Issue number	5
DOIs	https://doi.org/10.1001/jama.2020.8642
Publication status	Published - 4 Aug 2020

Keywords

@article{f2da0e8d3ffc416596b7139f39112079,

title = "Research and development costs of new drugs",

keywords = "Costs and Cost Analysis, Drug Costs, Investments",

author = "Bart Dierynck and P.P.M. Joos",

year = "2020",

month = aug,

day = "4",

doi = "10.1001/jama.2020.8642",

language = "English",

volume = "324",

pages = "516--517",

journal = "JAMA. The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Research and development costs of new drugs

AU - Dierynck, Bart

AU - Joos, P.P.M.

PY - 2020/8/4

Y1 - 2020/8/4

KW - Costs and Cost Analysis

KW - Drug Costs

KW - Investments

U2 - 10.1001/jama.2020.8642

DO - 10.1001/jama.2020.8642

M3 - Comment/Letter to the editor

C2 - 32749483

SN - 0098-7484

VL - 324

SP - 516

EP - 517

JO - JAMA. The Journal of the American Medical Association

JF - JAMA. The Journal of the American Medical Association

IS - 5

ER -